Jumat, 12 Juni 2026 - 08:42 WIB

Find and Follow Us

Global Markets

IHSG 5,886.03 -0.28%

S&P 500 7,394.30 +1.75%

NASDAQ 25,809.66 +2.54%

Dow Jones 50,848.75 +1.86%

FTSE 100 10,303.90 +0.48%

CAC 40 8,200.80 +0.48%

Nikkei 225 66,136.95 +2.99%

Hang Seng 24,501.50 +1.04%

Shanghai 3,987.02 +0.00%

KOSPI 8,314.56 +7.09%

STI 5,011.28 +0.46%

ASX 200 8,795.40 +1.88%

Sensex 73,832.55 -0.20%

Gold 4,203.40 +2.32%

Silver 66.74 +3.31%

Oil (WTI) 86.70 -3.70%

Brent 89.41 -3.96%

Copper 6.38 +2.06%

Gas Alam 3.08 -3.45%

Bitcoin 63,282.53 +0.00%

Ethereum 1,662.00 +0.00%

USD/IDR 17,975.00 +0.55%

EUR/USD 1.16 +0.28%

Advertisement

Ilustrasi penelitian vaksin (rino/industry.co.id)

Kabar Gembira, Gandeng LBM Eijkman dan Sinovac China, PT Bio Farma Siap Produksi Masal Vaksin Covid-19

Redaksi • 07 Mei 2020

Latest Updates

- Advertisement -

Ilustrasi penelitian vaksin (rino/industry.co.id)

16:15 WIB • 07 Mei 2020

Kabar Gembira, Gandeng LBM Eijkman dan Sinovac China, PT Bio Farma Siap Produksi Masal Vaksin Covid-19

Bantu tangani kasus Covid-19, PT Bio Farma (Persero) berpartisipasi dalam mengembangkan vaksin covid-19 baik dalam negeri…